KCM
BIIB icon

Kennedy Capital Management’s Biogen BIIB Stock Holding History

Kennedy Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
10,098
+290
+3% +$55.5K 0.04% 444
2026
Q1 		$1.8M Buy
9,808
+805
+9% +$148K 0.04% 432
2025
Q4 		$1.58M Buy
9,003
+166
+2% +$27.1K 0.03% 443
2025
Q3 		$1.24M Buy
8,837
+4,334
+96% +$586K 0.03% 486
2025
Q2 		$566K Buy
4,503
+52
+1% +$6.48K 0.01% 541
2025
Q1 		$609K Buy
4,451
+56
+1% +$8.01K 0.01% 571
2024
Q4 		$672K Buy
4,395
+815
+23% +$137K 0.01% 624
2024
Q3 		$694K Buy
3,580
+642
+22% +$134K 0.02% 623
2024
Q2 		$681K Buy
2,938
+618
+27% +$134K 0.01% 620
2024
Q1 		$500K Buy
+2,320
New +$543K 0.01% 658

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kennedy Capital Management's BIIB Position: Q2 2026 in Review

Kennedy Capital Management increased its Biogen (BIIB) stake by 3% in Q2 2026, buying an estimated $55.5K and bringing the position to 10,098 shares worth $2.18M. The position accounts for 0.04% of the portfolio, ranked #444.

Kennedy Capital Management first reported a position in BIIB in Q1 2024 and has held it in 10 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Kennedy Capital Management held 10,098 shares of Biogen worth $2.18M as of Q2 2026.
  • Kennedy Capital Management bought 290 Biogen shares in Q2 2026, an estimated $55.5K.
  • Biogen made up 0.04% of Kennedy Capital Management's portfolio in Q2 2026, its #444 holding.
  • Kennedy Capital Management first reported a position in Biogen in Q1 2024 and has held it in 10 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.